Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
08 mars 2017 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
Agile Therapeutics to Present at the 2017 BIO CEO & Investor Conference
02 févr. 2017 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al...
Agile Therapeutics Announces Positive Top-line Phase 3 Results
03 janv. 2017 16h11 HE
|
Agile Therapeutics, Inc.
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey’s Technology Business Tax Certificate Transfer Program
01 déc. 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company announced today that it has received net proceeds of...
Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial
07 nov. 2016 16h10 HE
|
Agile Therapeutics, Inc.
Top-Line Data Expected in Early January 2017; Resubmission Planned for First Half 2017 Cash Expected to Fund Operations Through the End of 2017 PRINCETON, N.J., Nov. 07, 2016 (GLOBE...
Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors
28 juil. 2016 16h11 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 28, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced the appointment of Seth H. Z. Fischer to the Company's Board of Directors, effective July...
Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline
12 juil. 2016 16h12 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs
16 juin 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference
07 juin 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 07, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference
02 juin 2016 17h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 02, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...